Clinical experience using trofinetide in Rett syndrome and related MECP2 diagnosis at the children's hospital of Philadelphia post approval.

Prange EO, Fleysh D, Reddy K, Dubbs H, Marsh ED

Open source

DOI
10.3389/fneur.2026.1776146
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1776146,
  title = {Clinical experience using trofinetide in Rett syndrome and related MECP2 diagnosis at the children's hospital of Philadelphia post approval.},
  author = {Prange EO and Fleysh D and Reddy K and Dubbs H and Marsh ED},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1776146},
  url = {https://doi.org/10.3389/fneur.2026.1776146}
}

RIS

TY  - JOUR
TI  - Clinical experience using trofinetide in Rett syndrome and related MECP2 diagnosis at the children's hospital of Philadelphia post approval.
AU  - Prange EO
AU  - Fleysh D
AU  - Reddy K
AU  - Dubbs H
AU  - Marsh ED
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1776146
UR  - https://doi.org/10.3389/fneur.2026.1776146
ER  - 

APA

EO, P., D, F., K, R., H, D., & ED, M. (2026). Clinical experience using trofinetide in Rett syndrome and related MECP2 diagnosis at the children's hospital of Philadelphia post approval.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1776146

Source records